Shareholder Sphera Funds Management LTD Has Raised Mylan N V (MYL) Holding; Cigna (CI) Holder Investec Asset Management LTD Has Decreased Its Stake as Market Valuation Declined

April 24, 2018 - By Peter Erickson

Mylan N.V. (NASDAQ:MYL) Logo

Sphera Funds Management Ltd increased its stake in Mylan N V (MYL) by 404.3% based on its latest 2017Q4 regulatory filing with the SEC. Sphera Funds Management Ltd bought 606,449 shares as the company’s stock declined 5.99% with the market. The institutional investor held 756,449 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $32.01M, up from 150,000 at the end of the previous reported quarter. Sphera Funds Management Ltd who had been investing in Mylan N V for a number of months, seems to be bullish on the $20.99B market cap company. The stock increased 0.15% or $0.06 during the last trading session, reaching $40.78. About 2.46 million shares traded. Mylan N.V. (NASDAQ:MYL) has declined 5.23% since April 24, 2017 and is downtrending. It has underperformed by 16.78% the S&P500.

Investec Asset Management Ltd decreased its stake in Cigna Corp (CI) by 0.54% based on its latest 2017Q4 regulatory filing with the SEC. Investec Asset Management Ltd sold 9,976 shares as the company’s stock declined 18.61% with the market. The institutional investor held 1.84 million shares of the medical specialities company at the end of 2017Q4, valued at $373.61 million, down from 1.85 million at the end of the previous reported quarter. Investec Asset Management Ltd who had been investing in Cigna Corp for a number of months, seems to be less bullish one the $41.92B market cap company. The stock increased 1.42% or $2.41 during the last trading session, reaching $172.35. About 2.38 million shares traded. Cigna Corporation (NYSE:CI) has risen 13.35% since April 24, 2017 and is uptrending. It has outperformed by 1.80% the S&P500.

Investec Asset Management Ltd, which manages about $24.34B US Long portfolio, upped its stake in Simon Property Group Inc (NYSE:SPG) by 25,500 shares to 151,457 shares, valued at $26.01 million in 2017Q4, according to the filing. It also increased its holding in Enbridge Inc (NYSE:ENB) by 384,260 shares in the quarter, for a total of 1.06M shares, and has risen its stake in Unum Group (NYSE:UNM).

Since December 11, 2017, it had 0 insider purchases, and 10 insider sales for $17.30 million activity. Another trade for 400 shares valued at $85,184 was sold by HENNEY JANE E MD. Another trade for 36,769 shares valued at $7.05 million was made by Cordani David on Friday, March 2. Another trade for 212 shares valued at $44,382 was made by HARRIS ISAIAH JR on Monday, December 11. Jones Nicole S sold $1.12 million worth of stock. Hocevar Christopher J sold $529,287 worth of stock. On Wednesday, January 10 the insider ZOLLARS WILLIAM D sold $43,604.

Among 22 analysts covering CIGNA (NYSE:CI), 18 have Buy rating, 0 Sell and 4 Hold. Therefore 82% are positive. CIGNA had 65 analyst reports since July 27, 2015 according to SRatingsIntel. As per Monday, June 5, the company rating was maintained by UBS. The firm has “Buy” rating by Oppenheimer given on Friday, August 4. Cowen & Co maintained Cigna Corporation (NYSE:CI) on Thursday, July 13 with “Buy” rating. Morgan Stanley maintained Cigna Corporation (NYSE:CI) rating on Friday, February 2. Morgan Stanley has “Overweight” rating and $255 target. The stock has “Buy” rating by RBC Capital Markets on Thursday, October 12. Jefferies maintained the stock with “Buy” rating in Tuesday, September 5 report. As per Monday, May 8, the company rating was maintained by RBC Capital Markets. The firm has “Buy” rating given on Thursday, February 1 by Jefferies. The stock has “Overweight” rating by Morgan Stanley on Monday, August 7. RBC Capital Markets maintained Cigna Corporation (NYSE:CI) on Sunday, July 23 with “Buy” rating.

Analysts await Cigna Corporation (NYSE:CI) to report earnings on May, 3 before the open. They expect $3.39 EPS, up 22.38% or $0.62 from last year’s $2.77 per share. CI’s profit will be $824.58 million for 12.71 P/E if the $3.39 EPS becomes a reality. After $1.94 actual EPS reported by Cigna Corporation for the previous quarter, Wall Street now forecasts 74.74% EPS growth.

Investors sentiment decreased to 0.91 in 2017 Q4. Its down 0.05, from 0.96 in 2017Q3. It dropped, as 38 investors sold CI shares while 280 reduced holdings. 92 funds opened positions while 197 raised stakes. 208.24 million shares or 0.93% more from 206.32 million shares in 2017Q3 were reported. Hanson Doremus Investment Mgmt holds 0.06% or 817 shares in its portfolio. Parsons Capital Management Ri stated it has 0.04% of its portfolio in Cigna Corporation (NYSE:CI). Supplemental Annuity Collective Of Nj owns 7,000 shares for 0.6% of their portfolio. Lmr Prtnrs Limited Liability Partnership reported 10,928 shares. Northpointe Cap Ltd invested in 16,762 shares or 0.38% of the stock. Old Mutual Customised Solutions (Proprietary) Limited accumulated 14,244 shares. Mairs And Pwr owns 4,559 shares. The Massachusetts-based Ngam Advsrs Lp has invested 0.09% in Cigna Corporation (NYSE:CI). Endurant Mgmt Lp stated it has 2,000 shares. Norinchukin Bank The invested 0.07% of its portfolio in Cigna Corporation (NYSE:CI). Hbk Ltd Partnership stated it has 156,000 shares or 0.3% of all its holdings. Lord Abbett And Lc holds 20,800 shares. Mckinley Capital Mngmt Delaware invested 0.54% of its portfolio in Cigna Corporation (NYSE:CI). Moors And Cabot reported 5,153 shares or 0.14% of all its holdings. Zurcher Kantonalbank (Zurich Cantonalbank) invested in 0.23% or 128,589 shares.

Sphera Funds Management Ltd, which manages about $852.23 million US Long portfolio, decreased its stake in Biogen Inc (NASDAQ:BIIB) by 30,800 shares to 74,200 shares, valued at $23.64M in 2017Q4, according to the filing. It also reduced its holding in Cellcom Israel Ltd (NYSE:CEL) by 176,244 shares in the quarter, leaving it with 1.36 million shares, and cut its stake in Global Blood Therapeutics In.

Cigna Corporation (NYSE:CI) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>